Using a glucose measurement system in intensive care for patients with shock
Official title: Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medicine
Run by Centre Hospitalier Universitaire de Nice · NCT04910841 · Data updated 2026-11-12
This study is testing a new glucose monitoring system to see if it can help make checking blood sugar easier and more comfortable for patients in intensive care who are dealing with septic shock.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 55 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Nice Academic / other |
| Locations | 1 site (Nice) |
| Status | Recruiting |
| Started | September 11, 2023 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT04910841 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients in septic shock with arterial hypotension requiring noradrenaline and hyperglycemia needing insulin therapy.
✕Probably not a fit
Patients who are under guardianship, pregnant, or breastfeeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility of the 'CGM GUARDIAN 2' system for monitoring glucose levels in patients experiencing hyperglycemia due to septic shock in intensive care units. The traditional method of blood glucose monitoring involves painful capillary sampling every two hours, which can lead to discomfort and sleep disturbances. The 'CGM GUARDIAN 2' system uses a subcutaneously placed electrode to measure glucose levels in interstitial fluid, potentially reducing the need for frequent blood draws. This approach aims to improve patient comfort and glycemic control in critically ill patients.
Why it matters
Potential benefit: If successful, this study could enhance glucose monitoring in intensive care, leading to better management of hyperglycemia and improved patient outcomes.
How similar studies have gone: While the use of continuous glucose monitoring systems has been validated in diabetic patients, this specific application in intensive care settings is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient in septic shock * Arterial hypotension requiring noradrenaline * Hyperglycaemia requiring insulin therapy Exclusion Criteria: * Patients under guardianship, curatorship or deprived of liberty * Pregnant or breastfeeding women
Where it's running
-
CHU de Nice
Nice, France Recruiting
Study contacts
- Principal investigator: Florent BILGER — Centre Hospitalier Universitaire de Nice
- Study coordinator: Florent BILGER
- Email: bilger.f@chu-nice.fr
- Phone: 492035510
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early treatment with noradrenaline for shock in emergency departments
This study tests if giving noradrenaline right away helps people in shock feel better and recover faster than just using standard fluids.
-
Cardiac Arrest: Using Ultrasound to Find Hidden Blood Flow
This study tests whether patients who have out-of-hospital cardiac arrest but no pulse still show some blood flow on ultrasound and whether that finding relates to survival.
-
Maltodextrin vs Sugar Water for Pre-Surgery Carbohydrate Loading in Older Adults
This study tests whether a maltodextrin drink before surgery leaves less fluid in the stomach than sugar water for adults 60 and older undergoing leg surgery with spinal or epidural anesthesia.
-
Managing pasireotide-related high blood sugar in acromegaly with a ketogenic diet
This study tests whether a very-low carbohydrate ketogenic diet can help lower HbA1c and fasting glucose in adults with acromegaly who develop high blood sugar while taking pasireotide.
-
Risk-stratified management of inavolisib-induced hyperglycemia in breast cancer patients
This observational study tests whether using a pre-treatment risk-stratified plan to manage high blood sugar from inavolisib helps patients stay on therapy.
-
Perfusion Index as a Predictor of Spinal Anesthesia–Induced Hypotension in Day-Case Knee Arthroscopy
This study looks to see if a baseline perfusion index can predict low blood pressure after spinal anesthesia in healthy adults having knee arthroscopy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.